United States Securities and Exchange Commission · EDGAR Accession 0001872856-26-000047

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-36737
Issuer CIK 2103503
Raising via DEALMAKER SECURITIES LLC

BioXgen Holdings, Inc.

CorporationDEIncorporated 2025TUCSON, AZbioxgen.life
Progress updateThe Offering successfully reached its Target Offering Amount on February 9, 2026, having closed on $29,757.91 of funds.
A

The Offering

as disclosed in this filing
Other (Units of the Co-Issuer corresponding with Class C Common Stock of the Issuer)
$1.43
$25,000
$5,000,000
May 15, 2026
Expired 30 days ago
$0max $5,000,000

Target is 1% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenue0 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income00
Total assets00
Cash & equivalents160,0000
Accounts receivable00
Short-term debt00
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36737 · all filings under this campaign
Loading campaign history…